Laboratorios Farmaceuticos Rovi SA
- BID
58.65
- ASK
58.8
- 171 Units415 Units
- 07/24, 21:59:59 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
8.72%
Market Cap
3.00 Bil.
P/E Ratio
23.13
Dividend Yield
1.22 %
Earnings per Share
2.75 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 58.6 G | 0 Units |
| PRICE DETERMINATION TIME | 07/24/2026 / 09:57:09 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 59 | 57.7 |
| PREV. DAY'S PRICE | 58.45 | (07/23) |
| CHANGE DAY BEFORE | +0.15 | 0.26 % |
| 52 WEEK HIGH / LOW | 86.55 (04/21) | 51.65 (08/06) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 3.29 | 2.68 | 2.75 | 2.50 | 3.43 |
DIVIDENDS PER SHARE | 0.89 | 0.76 | 0.78 | 0.96 | 1.18 |
DIVIDEND YIELD IN % | 1.49 % | 1.20 % | 1.22 % | - | - |
DIVIDEND GROWTH IN % | -14.69 % | -15.28 % | 2.60 % | - | - |
PRICE - EARNINGS RATIO | 18.31 | 23.52 | 23.13 | 23.24 | 16.94 |
PRICE - BOOK RATIO | 5.78 | 5.63 | 4.89 | - | - |
PRICE - SALES RATIO | 3.76 | 4.22 | 4.37 | - | - |
PRICE - CASH FLOW RATIO | 27.28 | 23.56 | 17.52 | - | - |
Master Data
| WKN | A0M0GQ |
| ISIN | ES0157261019 |
| SYMBOL | 41L |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | LABORATORIOS FARMACEUT. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Euro |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 51.15 Mil. |
| MARKET CAPITALISATION | 3.00 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 8.82 % | -1.10 % | -27.92 % | -19.95 % | 8.72 % | 40.39 % | -0.34 % | -6.91 % |
| HIGH | 59.00 | 59.60 | 81.95 | 86.55 | 86.55 | 91.40 | 91.40 | 86.55 |
| LOW | 53.60 | 52.85 | 52.85 | 52.85 | 51.65 | 41.06 | 35.44 | 52.85 |
Dividende
pro Aktie
Company profile
Laboratorios Farmaceúticos Rovi SA engages in the research, development, manufacture, and marketing of small molecule and specialty biologic drugs. It operates through the following business segments: Manufacturing, Marketing, and Other. The Manufacturing segment obtains its income from service contracts that relate to the finalization of the pharmaceutical product production process for external entities and the manufacture of products to be subsequently marketed by other group companies. The Marketing segment purchases and sells pharmaceutical products. The Other segment includes other services, research, and development activities that are not significant for the group. The company was founded on December 21, 1946 and is headquartered in Madrid, Spain.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.